Company Filing History:
1 out of 1,579 
1 out of 1,036 
1 out of 5,444 
Years Active: 2025
Title: Matthew Gorman: Innovator in Glioma Treatment
Introduction
Matthew Gorman is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of medical research, particularly in the treatment of glioblastoma. His innovative approach utilizes Zika virus strains to combat this aggressive form of brain cancer.
Latest Patents
Matthew Gorman holds 1 patent for his work on Zika virus strains for the treatment of glioma. The patent details a composition and method for treating glioblastoma using the Zika virus, showcasing a novel approach to a challenging medical issue.
Career Highlights
Throughout his career, Gorman has worked with prestigious institutions such as Washington University and The Cleveland Clinic Foundation. His research has focused on developing innovative therapies that leverage viral mechanisms to target cancer cells effectively.
Collaborations
Matthew has collaborated with notable colleagues, including Michael S. Diamond and Milan Chheda, who have contributed to his research endeavors.
Conclusion
Matthew Gorman's work exemplifies the intersection of innovation and medical research, particularly in the fight against glioblastoma. His contributions are paving the way for new treatment methodologies that could significantly impact patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.